Clinical oncology updates: Progress and mechanisms of new anticancer drugsEuropean journal of cancer (1990). 1998, Vol 34, Num 10, pp 1491-1548, issn 0959-8049Conference Proceedings

Cellular and molecular determinants of cisplatin resistancePEREZ, R. P.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1535-1542, issn 0959-8049Conference Paper

Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcomaTAVIO, M; NASTI, G; SIMONELLI, C et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1634-1637, issn 0959-8049Conference Paper

Pharmacogenetics and cancer chemotherapyIYER, L; RATAIN, M. J.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1493-1499, issn 0959-8049Conference Paper

Should systematic lymph node dissection be recommended for gastric cancer?MARUYAMA, K; SASAKO, M; KINOSHITA, T et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1480-1489, issn 0959-8049Conference Paper

Camptothecins : a review of their development and schedules of administrationO'LEARY, J; MUGGIA, F. M.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1500-1508, issn 0959-8049Conference Paper

Decreased expression of CD44 splicing variants in advanced colorectal carcinomasWEG-REMERS, S; ANDERS, M; VON LAMPE, B et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1607-1611, issn 0959-8049Conference Paper

The clinical development of paclitaxel and the paclitaxel/carboplatin combinationSCHWARTZ, G. N; PENDYALA, L; KINDLER, H et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1543-1548, issn 0959-8049Conference Paper

Attitudes of patients to randomised clinical trials of cancer therapyFALLOWFIELD, L. J; JENKINS, V; BRENNAN, C et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1554-1559, issn 0959-8049Conference Paper

Oral fluoropyrimidines in the treatment of colorectal cancerMEROPOL, N. J.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1509-1513, issn 0959-8049Conference Paper

Autoregulation of 5-fluorouracil metabolismMCLEOD, H. L; SLUDDEN, J; HARDY, S. C et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1623-1627, issn 0959-8049Conference Paper

Etoposide : Four decades of development of a topoisomerase II inhibitorHANDE, K. R.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1514-1521, issn 0959-8049Conference Paper

Expression of cyclin D1 and retinoblastoma protein in colorectal cancerPALMQVIST, R; STENLING, R; ÖBERG, A et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1575-1581, issn 0959-8049Conference Paper

Cancer genetic clinics : Why do women who already have cancer attend?JULIAN-REYNIER, C; EISINGER, F; CHABAL, F et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1549-1553, issn 0959-8049Conference Paper

Clinical development of platinum complexes in cancer therapy : an historical perspective and an updateLEBWOHL, D; CANETTA, R.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1522-1534, issn 0959-8049Conference Paper

Oral complications during treatment of malignant diseases in childhood : Effects of tooth brushingBONNAURE-MALLET, M; BUNETEL, L; TRICOT-DOLEUX, S et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1588-1591, issn 0959-8049Conference Paper

Long-term neuro-endocrine sequelae after treatment for childhood medulloblastomaHEIKENS, J; MICHIELS, E. M. C; BEHRENDT, H et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1592-1597, issn 0959-8049Conference Paper

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomasVAN DEN BENT, M. J; SCHELLENS, J. H. M; VECHT, C. J et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1570-1574, issn 0959-8049Conference Paper

Advance directives and other medical decisions concerning the end of life in cancer patients in JapanASAI, A; MIURA, Y; TANABE, N et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1582-1586, issn 0959-8049Conference Paper

Organised cervical cancer screening still leads to higher coverage than spontaneous screening in the NetherlandsBOS, A. B; VAN BALLEGOOIJEN, M; VAN GESSEL-DABEKAUSSEN, A. A. M. W et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1598-1601, issn 0959-8049Conference Paper

The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsBREISTØL, K; HENDRIKS, H. R; BERGER, D. P et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1602-1606, issn 0959-8049Conference Paper

Efficacy and toxicity of 2-chlorodeoxyadenosine (cladribine)-2 h infusion for 5 days-as first-line treatment for advanced low grade non-Hodgkin's lymphomaFRIDRIK, M. A; JÄGER, G; SCHILLER, L et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1560-1564, issn 0959-8049Conference Paper

Aggressive administration of recombinant oncotoxin AR209 (anti-ErbB-2) in athymic nude mice implanted with orthotopic human non-small cell lung tumoursSKREPNIK, N; ZIESKE, A. W; ROBERT, E et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1628-1633, issn 0959-8049Conference Paper

Comparative expression of major histocompatibility complex (MHC) antigens on CD5⁺ and CD5^- B cells in patients with chronic lymphocytic leukaemia (CLL)NOURI, A. M. E; SMITH, S; NEWLAND, A. C et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1618-1622, issn 0959-8049Conference Paper

Expression of MDR1 mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gall bladder cancer tissuesLIPING CAO; DUCHROW, M; WINDHÖVEL, U et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1612-1617, issn 0959-8049Conference Paper